Susquehanna Fundamental Investments, LLC Athenex, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $9,950 - $46,020	-41,460 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $31,692 - $68,510	-23,303 Reduced 35.98%	41,460 $56,000
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $98,776 - $160,968	-33,258 Reduced 33.93%	64,763 $195,000
Q2 2021 Aug 11, 2021	BUY	$3.71 - $5.13 $363,657 - $502,847	98,021 New	98,021 $453,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $758,716 - $961,086	-68,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $208,278 - $295,365	20,300 Added 42.03%	68,600 $830,000
Q2 2020 Aug 14, 2020	BUY	$7.11 - $13.76 $343,413 - $664,608	48,300 New	48,300 $665,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.